The intelligence edge for nuclear medicine professionals
Join executives, investors, and operators who start their day with the Nuclio Daily — the only daily intelligence service dedicated to the business of nuclear medicine.
What you'll receive
Market intelligence
Deal flow, financing rounds, and M&A activity across the radiopharmaceutical sector.
Executive moves
Leadership changes, board appointments, and key hires shaping the industry.
Regulatory updates
FDA decisions, EMA guidance, and policy developments affecting nuclear medicine.
Clinical milestones
Trial readouts, approvals, and pipeline progress from leading developers.
Supply chain
Isotope availability, manufacturing capacity, and logistics across the nuclear pharmacy network.
Events & conferences
Key industry gatherings, investor days, and scientific meetings.
Daily
Nuclear medicine intelligence
Executives, investors, clinicians, and policy professionals across the nuclear medicine economy.
Start your free subscription
Delivered every weekday morning. Cancel anytime.
Trusted by the people who run the industry
Nuclio Media is the first thing I read every morning. It's the only source that covers the business side of nuclear medicine with real depth.
Chief Business Officer
Leading radiopharmaceutical developer
The deal intelligence alone is worth the subscription. We've caught early signals on three transactions before they were public.
Managing Director
Healthcare-focused private equity
I forward the regulatory watch alerts to my entire team. It saves us hours of monitoring every week.
VP Regulatory Affairs
Global nuclear medicine company